Clinical trial
Effect of Real-time Pressure Controllers on Objective and Subjective Symptoms of Albumin Paclitaxel-induced Peripheral Neuropathy: a Prospective Controlled Research Project
NCT07019233 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Real-time Pressure Controllers on Objective and Subjective Symptoms of Albumin Paclitaxel-induced Peripheral Neuropathy: a Prospective Controlled Research Project
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 118 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
albumin paclitaxel, breast cancer, peripheral neuropathy, real time pressure controller